Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
Morning market movers: 8 stocks to watch
⏸️ Investing
These 10 blue chips smashed the market last week: Did you miss the chance to buy?
⏸️ Investing
Cochlear Limited surges 13%: Is it too late to buy?
⏸️ Investing
Cochlear Limited surges 5%: What shareholders need to know
⏸️ Investing
3 of my favourite growth stocks: Oil Search Limited, Amcor Limited and Cochlear Limited
⏸️ Investing
Does FlexiGroup Limited offer growth at a discount?
⏸️ Investing
Will the RBA cut interest rates tomorrow? Here's how to profit either way
⏸️ Investing
10 blue chip stocks to buy before Tuesday's rate cut
⏸️ Investing
Is it time to sell Cochlear Limited?
⏸️ Investing
3 top healthcare stocks for your watch list
⏸️ Investing
Cochlear Limited jumps on court ruling: Here's what you need to know
⏸️ Investing
Do you have the personality traits to help you become a better investor?
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
